The Significance of Visceral Pleural Surface Invasion in 321 Cases of Non-Small Cell Lung Cancers with Pleural Retraction

BackgroundIn order to improve prognostic applications and treatment decisions, we report our experiences of visceral pleural surface invasion (VPSI) in non-small cell lung cancers (NSCLCs) with pleural retraction.MethodsA total of 321 NSCLCs with pleural retraction were identified by carefully inspecting surgically resected specimens. The extent of pleural invasion, including the use of elastic stain, was evaluated. Patients with and without VPSI were compared for clinicopathologic parameters and survival.ResultsVPSI was identified in 170 (53.0 %) of the stage I–III cases and 98 (43.4 %) of the patients with stage I disease. VPSI was associated with a higher frequency of tumor size greater than 3 cm, moderate/poor differentiation, vascular invasion, mediastinal lymph node metastasis, extranodal involvement, and higher TNM stages. Multivariate analysis revealed VPSI to be a significant independent predictor of unfavorable prognosis. The 5-year survival of patients with and without VPSI was 57.9 and 83.0 %, respectively (P = 0.001), and was 74.3 and 88.5 % (P = 0.005) in stages I–III and stage I disease, respectively.ConclusionsVPSI is an independent factor for poor prognosis in NSCLCs, regardless of lymph node status. Stage IB NSCLCs with PL1 pleural invasion are associated with a survival rate similar to that of stage IA NSCLCs and could be classified as T1 lesions. While surgical treatment is adequate in these patients, stage IB NSCLCs with VPSI have poor prognosis, and these patients should be considered for adjuvant chemotherapy.

[1]  L. A. Brewer,et al.  Carcinoma of the lung; practical classification for early diagnosis and surgical treatment. , 1958, Journal of the American Medical Association.

[2]  N. Wang.  The preformed stomas connecting the pleural cavity and the lymphatics in the parietal pleura. , 1975, The American review of respiratory disease.

[3]  L. A. Brewer.  Patterns of survival in lung cancer. , 1977, Chest.

[4]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.

[5]  Bonny R. Hart,et al.  Prognostic significance of N1 disease in carcinoma of the lung. , 1983, The Journal of thoracic and cardiovascular surgery.

[6]  E. Diao,et al.  Common tumors. , 1992, The Orthopedic clinics of North America.

[7]  I Yoshino,et al.  Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. An analysis in each pathologic stage. , 1995, The Journal of thoracic and cardiovascular surgery.

[8]  S. Chevret,et al.  Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma: Correlation with TNM stage and disease free and overall survival , 1996, Cancer.

[9]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[10]  K. Honma,et al.  Lymph node metastasis in small peripheral adenocarcinoma of the lung. , 1998, The Journal of thoracic and cardiovascular surgery.

[11]  A. Dujon,et al.  Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor. , 2001, The Annals of thoracic surgery.

[12]  Y. Nishiwaki,et al.  Predictors of lymph node and intrapulmonary metastasis in clinical stage IA non-small cell lung carcinoma. , 2001, The Annals of thoracic surgery.

[13]  Fumihiro Tanaka,et al.  Pit-fall sign on computed tomography predicts pleural involvement and poor prognosis in non-small cell lung cancer. , 2004, Lung cancer.

[14]  Elisabeth Brambilla,et al.  Pathology and genetics of tumours of the lung , pleura, thymus and heart , 2004 .

[15]  K. Yasumoto,et al.  Visceral pleural involvement in nonsmall cell lung cancer: prognostic significance. , 2004, The Annals of thoracic surgery.

[16]  C. Foucault,et al.  Visceral pleura invasion and lung cancer: further clarifications. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[17]  Y. Nishiwaki,et al.  Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment. , 2004, The Journal of thoracic and cardiovascular surgery.

[18]  R. Rami-Porta,et al.  Complete resection in lung cancer surgery: proposed definition. , 2005, Lung cancer.

[19]  Y. Nishiwaki,et al.  Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. , 2005, The Journal of thoracic and cardiovascular surgery.

[20]  P. Jänne,et al.  Epidermal growth factor receptor mutations in patients with non-small cell lung cancer. , 2005, Cancer research.

[21]  P. Pairolero,et al.  Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival. , 2006, The Journal of thoracic and cardiovascular surgery.

[22]  M. Okumura,et al.  Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement. , 2006, The Journal of thoracic and cardiovascular surgery.

[23]  H. Wakelee,et al.  Lung cancer in women: exploring sex differences in susceptibility, biology, and therapeutic response. , 2006, Clinical lung cancer.

[24]  Yih-Leong Chang,et al.  Surgical treatment of synchronous multiple primary lung cancers: experience of 92 patients. , 2007, The Journal of thoracic and cardiovascular surgery.

[25]  K. Matsuo,et al.  Subcategorization of lung cancer based on tumor size and degree of visceral pleural invasion. , 2008, The Annals of thoracic surgery.

[26]  Kenji Eguchi,et al.  A Japanese Lung Cancer Registry Study: Prognosis of 13,010 Resected Lung Cancers , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[27]  A. Ochiai,et al.  Identification of a low risk subgroup of stage IB lung adenocarcinoma patients. , 2008, Lung cancer.

[28]  V. Rusch,et al.  Visceral Pleural Invasion: Pathologic Criteria and Use of Elastic Stains: Proposal for the 7th Edition of the TNM Classification for Lung Cancer , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[29]  G. Chang,et al.  Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease. , 2009, The Journal of thoracic and cardiovascular surgery.

[30]  P. Goldstraw.  Staging manual in thoracic oncology , 2009 .

[31]  K. Nagai,et al.  Visceral Pleural Invasion Classification in Non-small Cell Lung Cancer , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[32]  K. Nagai,et al.  Poor prognostic factors in patients with stage IB non-small cell lung cancer according to the seventh edition TNM classification. , 2011, Chest.

[33]  K. Nagai,et al.  Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification. , 2011, Chest.

[34]  A. Abernethy,et al.  Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer. , 2012, Lung cancer.